Concepedia

Author

David Lindley

AbbVie (United States)

Also Known As

DAVID LINDLEY, David J Lindley, David J. Lindley, David Lindley, T Lewis

247

Publications

1.4K

Citations

17

H-Index

70

Concepts

All Affiliations

AbbVie (United States)Ben-Gurion University of the NegevPfizer (United States)Purdue University West Lafayette
DL

About

David Lindley is an author at AbbVie (United States) specializing in medicine, pharmacology, and engineering.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

596

2

Engineering

6

6

161

3

Public Health

2

2

51

4

Biochemistry

2

2

91

5

Applied Physics

1

1

59

David Lindley

×

20

Publications

981

Citations

15

H-Index

YearCitations

The EED protein–protein interaction inhibitor A-395 inactivates the PRC2 complex

Yupeng He, Sujatha Selvaraju, Michael L. Curtin,

Nature Chemical Biology

2017

229

ABC and SLC Transporter Expression and Pot Substrate Characterization across the Human CMEC/D3 Blood−Brain Barrier Cell Line

Stephen M. Carl, David Lindley, P. O. Couraud,

Molecular Pharmaceutics

2010

96

Head-To-Head Comparison of Different Solubility-Enabling Formulations of Etoposide and Their Consequent Solubility–Permeability Interplay

Avital Beig, Jonathan M. Miller, David Lindley,

Journal of Pharmaceutical Sciences

2015

77

Mechanistic Physiologically Based Pharmacokinetic Modeling of the Dissolution and Food Effect of a Biopharmaceutics Classification System IV Compound—The Venetoclax Story

Arian Emami Riedmaier, David Lindley, Jeffrey A. Hall,

Journal of Pharmaceutical Sciences

2017

76

Advantageous Solubility-Permeability Interplay When Using Amorphous Solid Dispersion (ASD) Formulation for the BCS Class IV P-gp Substrate Rifaximin: Simultaneous Increase of Both the Solubility and the Permeability

Avital Beig, Noa Fine‐Shamir, David Lindley,

The AAPS Journal

2017

59

Hydrotropic Solubilization of Lipophilic Drugs for Oral Delivery: The Effects of Urea and Nicotinamide on Carbamazepine Solubility–Permeability Interplay

Avital Beig, David Lindley, Jonathan M. Miller,

Frontiers in Pharmacology

2016

55

Toward Successful Cyclodextrin Based Solubility-Enabling Formulations for Oral Delivery of Lipophilic Drugs: Solubility–Permeability Trade-Off, Biorelevant Dissolution, and the Unstirred Water Layer

Noa Fine‐Shamir, Avital Beig, Moran Zur,

Molecular Pharmaceutics

2017

52

Concomitant solubility-permeability increase: Vitamin E TPGS vs. amorphous solid dispersion as oral delivery systems for etoposide

Avital Beig, Noa Fine‐Shamir, Daniel Porat,

European Journal of Pharmaceutics and Biopharmaceutics

2017

48

Striking the Optimal Solubility–Permeability Balance in Oral Formulation Development for Lipophilic Drugs: Maximizing Carbamazepine Blood Levels

Avital Beig, Jonathan M. Miller, David Lindley,

Molecular Pharmaceutics

2016

41

Merck's new drug free to WHO for river blindness programme

David Lindley

Nature

1987

40

Page 1